» Articles » PMID: 17118637

Increased Proportion of Fas Positive CD8+ Cells in Peripheral Blood of Patients with COPD

Overview
Journal Respir Med
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2006 Nov 23
PMID 17118637
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD) is characterised by chronic inflammation in pulmonary tissue and is also associated with systemic effects. The objective of this study was determination of lymphocyte subpopulation and the expression of Fas receptor on lymphocytes derived from peripheral blood of patients with stable COPD (n=18) and a control group: asymptomatic smokers (n=12) and non-smokers (n=12). Flow cytometry method with monoclonal antibodies was used for evaluation of lymphocyte subsets: CD4+ and CD8+ and the expression of Fas (CD95) on T lymphocytes. We found an elevated proportion of CD8+ cells in the blood of COPD patients. Proportion of Fas+ T lymphocytes was significantly higher in patients with COPD when compared with asymptomatic smokers and non-smokers (mean: 84.4% vs. 71.6% vs. 61.0% for Fas+/ CD4+ and 88.1% vs. 73.8% vs. 58.3% for Fas+/CD8+ lymphocytes). The proportion of Fas positive CD8+ cells significantly correlated with the degree of airway obstruction and hypoxemia. The significant correlations of Fas positive CD4+ and Fas positive CD8+ with smoking history expressed as pack years smoked were observed. Our observation of an elevated proportion of circulating lymphocytes bearing Fas receptor may play a role in induction of these cells' apoptosis and indicate the role of Fas/ FasL pathway in the changes in proportion of lymphocyte subpopulations in patients with COPD.

Citing Articles

Lung Cancer in the Course of COPD-Emerging Problems Today.

Ulinski R, Kwiecien I, Domagala-Kulawik J Cancers (Basel). 2022; 14(15).

PMID: 35954482 PMC: 9367492. DOI: 10.3390/cancers14153819.


CD19 and POU2AF1 are Potential Immune-Related Biomarkers Involved in the Emphysema of COPD: On Multiple Microarray Analysis.

Zhang D, Ye J, Sun Y, Ji S, Kang J, Wei Y J Inflamm Res. 2022; 15:2491-2507.

PMID: 35479834 PMC: 9035466. DOI: 10.2147/JIR.S355764.


Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer.

Raguraman R, Srivastava A, Munshi A, Ramesh R Adv Drug Deliv Rev. 2021; 178:113918.

PMID: 34375681 PMC: 8556346. DOI: 10.1016/j.addr.2021.113918.


The role of CD8 + T lymphocytes in chronic obstructive pulmonary disease: a systematic review.

Williams M, Todd I, Fairclough L Inflamm Res. 2020; 70(1):11-18.

PMID: 33037881 PMC: 7806561. DOI: 10.1007/s00011-020-01408-z.


Immunomodulatory Molecules On Lung Cancer Stem Cells From Lymph Nodes Aspirates.

Raniszewska A, Kwiecien I, Sokolowski R, Rutkowska E, Domagala-Kulawik J Cancers (Basel). 2020; 12(4).

PMID: 32244422 PMC: 7226167. DOI: 10.3390/cancers12040838.